Abgenix Appoints Marc Better, Ph.D., as Vice President... -
[Cached Version]
Published on: 5/11/2005
Last Visited: 5/11/2005
Abgenix Appoints Marc Better, Ph.D., as Vice President of Process SciencesAbgenix Appoints Marc Better, Ph.D., as Vice President of Process Sciences
...
Abgenix Appoints Marc Better, Ph.D., as Vice President of Process Sciences
...
FREMONT, Calif., May 11 /PRNewswire-FirstCall/ -- Abgenix, Inc. (Nasdaq: ABGX), a biopharmaceutical company focused on development of antibody therapeutics, announced today the appointment of Marc Better, Ph.D., as Vice President of Process Sciences.
"We are pleased to have Marc join our company.
...
Before joining Abgenix, Dr. Better was vice president, technical development at XOMA (US) LLC.He was responsible for process development and clinical manufacturing operations in the XOMA pilot facility.During his sixteen-year tenure at XOMA, Dr. Better made significant contributions to XOMA's technology platforms for product development, including gene cloning and expression in bacterial, fungal and mammalian cell systems, as well as protein and peptide recovery and purification.
From 1984 to 1989, Dr. Better held various research positions at International Genetic Engineering, Inc. (INGENE), which later merged with XOMA.
Dr. Better is the inventor of more than 20 patents issued in the U.S. and Europe.
He earned a Ph.D. in biochemistry from Brandeis University, and holds a B.S. in microbiology from Michigan State University.In addition, he worked as a postdoctoral fellow at the University of California at San Diego.